Intracellular detection of differential APOBEC3G, TRIM5alpha, and LEDGF/p75 protein expression in peripheral blood by flow cytometry

Journal of Immunological Methods

Volumn 372, Issue 1-2, 2011, Pages 52-64

  Mous, Kim ^a   Jennes, Wim ^b   De Roo, Ann ^b   Pintelon, Isabel ^a   Kestens, Luc ^b   Van Ostade, Xaveer ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

APOBEC3G; Intracellular staining; LEDGF p75; Protein expression; TRIM5alpha

Indexed keywords

ALPHA INTERFERON; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; BETA INTERFERON; CD16 ANTIGEN; CD4 ANTIGEN; LENS EPITHELIUM DERIVED GROWTH FACTOR; MITOGENIC AGENT; PROTEIN P75; RECOMBINANT PROTEIN; TRIPARTITE MOTIF PROTEIN 5;

ARTICLE; CD4+ T LYMPHOCYTE; CELL LINE; CELL NUCLEUS; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCUBATION TIME; INDIRECT INTRACELLULAR STAINING; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STAINING; VIRUS REPLICATION; WESTERN BLOTTING;

CARRIER PROTEINS; CYTIDINE DEAMINASE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES, MONONUCLEAR; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80052451877     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2011.06.028     Document Type: Article

References (60)

1. Argyris E.G., Acheampong E., Wang F., Huang J., Chen K., Mukhtar M., Zhang H. The interferon-induced expression of APOBEC3G in human blood-brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous system. Virology 2007, 367:440.
2. Asaoka K., Ikeda K., Hishinuma T., Horie-Inoue K., Takeda S., Inoue S. A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons. Biochem. Biophys. Res. Commun. 2005, 338:1950.
3. Biasin M., Piacentini L., Caputo S.L., Kanari Y., Magri G., Trabattoni D., Naddeo V., Lopalco L., Clivio A., Cesana E., Fasano F., Bergamaschi C., Mazzotta F., Miyazawa M., Clerici M. Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals. J. Infect. Dis. 2007, 195:960.
4. Black L.R., Aiken C. TRIM5alpha disrupts the structure of assembled HIV-1 capsid complexes in vitro. J. Virol. 2010, 84:6564.
5. Brenchley J.M., Hill B.J., Ambrozak D.R., Price D.A., Guenaga F.J., Casazza J.P., Kuruppu J., Yazdani J., Migueles S.A., Connors M., Roederer M., Douek D.C., Koup R.A. T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J. Virol. 2004, 78:1160.
6. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., Vandesompele J., Wittwer C.T. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 2009, 55:611.
7. Camara M., Dieye T.N., Seydi M., Diallo A.A., Fall M., Diaw P.A., Sow P.S., Mboup S., Kestens L., Jennes W. Low-level CD4+ T cell activation in HIV-exposed seronegative subjects: influence of gender and condom use. J. Infect. Dis. 2010, 201:835.
8. Carthagena L., Parise M.C., Ringeard M., Chelbi-Alix M.K., Hazan U., Nisole S. Implication of TRIM alpha and TRIMCyp in interferon-induced anti-retroviral restriction activities. Retrovirology 2008, 5:59.
9. Chen K., Huang J., Zhang C., Huang S., Nunnari G., Wang F.X., Tong X., Gao L., Nikisher K., Zhang H. Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells. J. Virol. 2006, 80:7645.
10. Cherepanov P., Maertens G., Proost P., Devreese B., Van B.J., Engelborghs Y., De C.E., Debyser Z. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J. Biol. Chem. 2003, 278:372.
11. Chiu Y.L., Greene W.C. Multifaceted antiviral actions of APOBEC3 cytidine deaminases. Trends Immunol. 2006, 27:291.
12. Chiu Y.L., Soros V.B., Kreisberg J.F., Stopak K., Yonemoto W., Greene W.C. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 2005, 435:108.
13. Chiu Y.L., Soros V.B., Kreisberg J.F., Stopak K., Yonemoto W., Greene W.C. Cellular APOBEC3G restricts HIV-1 infection in resting CD4(+) T cells. Nature 2010, 466:276.
14. Cho S.J., Drechsler H., Burke R.C., Arens M.Q., Powderly W., Davidson N.O. APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count. J. Virol. 2006, 80:2069.
15. Chylack L.T., Fu L., Mancini R., Martin-Rehrmann M.D., Saunders A.J., Konopka G., Tian D., Hedley-Whyte E.T., Folkerth R.D., Goldstein L.E. Lens epithelium-derived growth factor (LEDGF/p75) expression in fetal and adult human brain. Exp. Eye Res. 2004, 79:941.
16. Ciuffi A., Llano M., Poeschla E., Hoffmann C., Leipzig J., Shinn P., Ecker J.R., Bushman F. A role for LEDGF/p75 in targeting HIV DNA integration. Nat. Med. 2005, 11:1287.
17. Conticello S.G., Thomas C.J., Petersen-Mahrt S.K., Neuberger M.S. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol. Biol. Evol. 2005, 22:367.
18. Dai J., Agosto L.M., Baytop C., Yu J.J., Pace M.J., Liszewski M.K., O'Doherty U. Human immunodeficiency virus integrates directly into naive resting CD4+ T cells but enters naive cells less efficiently than memory cells. J. Virol. 2009, 83:4528.
19. Ellery P.J., Tippett E., Chiu Y.L., Paukovics G., Cameron P.U., Solomon A., Lewin S.R., Gorry P.R., Jaworowski A., Greene W.C., Sonza S., Crowe S.M. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J. Immunol. 2007, 178:6581.
20. Ge H., Si Y., Roeder R.G. Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. EMBO J. 1998, 17:6723.
21. Greene W.C., Debyser Z., Ikeda Y., Freed E.O., Stephens E., Yonemoto W., Buckheit R.W., Este J.A., Cihlar T. Novel targets for HIV therapy. Antivir. Res. 2008, 80:251.
22. Harris R.S., Petersen-Mahrt S.K., Neuberger M.S. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell 2002, 10:1247.
23. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., Malim M.H. DNA deamination mediates innate immunity to retroviral infection. Cell 2003, 113:803.
24. Jaworowski A., Kamwendo D.D., Ellery P., Sonza S., Mwapasa V., Tadesse E., Molyneux M.E., Rogerson S.J., Meshnick S.R., Crowe S.M. CD16+ monocyte subset preferentially harbors HIV-1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV-1 infection. J. Infect. Dis. 2007, 196:38.
25. Jennes W., Camara M., Dieye T., Mboup S., Kestens L. Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infection. J. Virol. 2008, 82:8619.
26. Jin X., Brooks A., Chen H., Bennett R., Reichman R., Smith H. APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia. J. Virol. 2005, 79:11513.
27. Kamata M., Nagaoka Y., Chen I.S. Reassessing the role of APOBEC3G in human immunodeficiency virus type 1 infection of quiescent CD4+ T-cells. PLoS Pathog. 2009, 5:e1000342.
28. Koning F.A., Newman E.N., Kim E.Y., Kunstman K.J., Wolinsky S.M., Malim M.H. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J. Virol. 2009, 83:9474.
29. Lamoreaux L., Roederer M., Koup R. Intracellular cytokine optimization and standard operating procedure. Nat. Protoc. 2006, 1:1507.
30. Lecossier D., Bouchonnet F., Clavel F., Hance A.J. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 2003, 300:1112.
31. Li X., Gold B., O'hUigin C., Diaz-Griffero F., Song B., Si Z., Li Y., Yuan W., Stremlau M., Mische C., Javanbakht H., Scally M., Winkler C., Dean M., Sodroski J. Unique features of TRIM5alpha among closely related human TRIM family members. Virology 2007, 360:419.
32. Maddon P.J., Dalgleish A.G., McDougal J.S., Clapham P.R., Weiss R.A., Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986, 47:333.
33. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003, 424:99.
34. Nishizawa Y., Usukura J., Singh D.P., Chylack L.T., Shinohara T. Spatial and temporal dynamics of two alternatively spliced regulatory factors, lens epithelium-derived growth factor (ledgf/p75) and p52, in the nucleus. Cell Tissue Res. 2001, 305:107.
35. Nisole S., Stoye J.P., Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 2005, 3:799.
36. Peng G., Lei K.J., Jin W., Greenwell-Wild T., Wahl S.M. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J. Exp. Med. 2006, 203:41.
37. Peng G., Greenwell-Wild T., Nares S., Jin W., Lei K.J., Rangel Z.G., Munson P.J., Wahl S.M. Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 2007, 110:393.
38. Redel L., Le D.V., Cherrier T., Marban C., Janossy A., Aunis D., Van L.C., Rohr O., Schwartz C. HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes. J. Leukoc. Biol. 2010, 87:575.
39. Refsland E.W., Stenglein M.D., Shindo K., Albin J.S., Brown W.L., Harris R.S. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res. 2010, 38:4274.
40. Rold C.J., Aiken C. Proteasomal degradation of TRIM5alpha during retrovirus restriction. PLoS Pathog. 2008, 4:e1000074.
41. Rose K.M., Marin M., Kozak S.L., Kabat D. Transcriptional regulation of APOBEC3G, a cytidine deaminase that hypermutates human immunodeficiency virus. J. Biol. Chem. 2004, 279:41744.
42. Sakuma R., Mael A.A., Ikeda Y. Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells. J. Virol. 2007, 81:10201.
43. Santoni de Sio F.R., Trono D. APOBEC3G-depleted resting CD4+ T cells remain refractory to HIV1 infection. PLoS. One. 2009, 4:e6571.
44. Sarkis P.T., Ying S., Xu R., Yu X.F. STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-alpha. J. Immunol. 2006, 177:4530.
45. Sewram S., Singh R., Kormuth E., Werner L., Mlisana K., Karim S.S., Ndung'u T. Human TRIM5alpha expression levels and reduced susceptibility to HIV-1 infection. J. Infect. Dis. 2009, 199:1657.
46. Sheehy A.M., Gaddis N.C., Choi J.D., Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418:646.
47. Song B., Diaz-Griffero F., Park D.H., Rogers T., Stremlau M., Sodroski J. TRIM5alpha association with cytoplasmic bodies is not required for antiretroviral activity. Virology 2005, 343:201.
48. Sonza S., Maerz A., Deacon N., Meanger J., Mills J., Crowe S. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J. Virol. 1996, 70:3863.
49. Spina C.A., Prince H.E., Richman D.D. Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. J. Clin. Investig. 1997, 99:1774.
50. Stopak K.S., Chiu Y.L., Kropp J., Grant R.M., Greene W.C. Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. J. Biol. Chem. 2006, 282:3539.
51. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848.
52. Stremlau M., Perron M., Welikala S., Sodroski J. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. J. Virol. 2005, 79:3139.
53. Stremlau M., Perron M., Lee M., Li Y., Song B., Javanbakht H., Diaz-Griffero F., Anderson D.J., Sundquist W.I., Sodroski J. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. U. S. A 2006, 103:5514.
54. Taylor M.W., Grosse W.M., Schaley J.E., Sanda C., Wu X., Chien S.C., Smith F., Wu T.G., Stephens M., Ferris M.W., McClintick J.N., Jerome R.E., Edenberg H.J. Global effect of PEG-IFN-alpha and ribavirin on gene expression in PBMC in vitro. J. Interferon Cytokine Res. 2004, 24:107.
55. Vetter M.L., Johnson M.E., Antons A.K., Unutmaz D., D'Aquila R.T. Differences in APOBEC3G expression in CD4+ T helper lymphocyte subtypes modulate HIV-1 infectivity. PLoS Pathog. 2009, 5:e1000292.
56. Wang Y., Bergmeier L.A., Stebbings R., Seidl T., Whittall T., Singh M., Berry N., Almond N., Lehner T. Mucosal immunization in macaques upregulates the innate APOBEC 3G anti-viral factor in CD4(+) memory T cells. Vaccine 2009, 27:870.
57. Weber C., Belge K.U., von H.P., Draude G., Steppich B., Mack M., Frankenberger M., Weber K.S., Ziegler-Heitbrock H.W. Differential chemokine receptor expression and function in human monocyte subpopulations. J. Leukoc. Biol. 2000, 67:699.
58. Wichroski M.J., Ichiyama K., Rana T.M. Analysis of HIV-1 viral infectivity factor-mediated proteasome-dependent depletion of APOBEC3G: correlating function and subcellular localization. J. Biol. Chem. 2005, 280:8387.
59. Ying S., Zhang X., Sarkis P.T., Xu R., Yu X. Cell-specific regulation of APOBEC3F by interferons. Acta Biochim. Biophys. Sin. (Shanghai) 2007, 39:297.
60. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 2003, 424:94.